Evidence map›Paper›PMID 30138905›Full record

Observational studyJournal of critical care2018

Progressive myocardial injury is associated with mortality in the acute respiratory distress syndrome.

Thomas S Metkus, Eliseo Guallar, Lori Sokoll, David A Morrow, Gordon Tomaselli, Roy Brower, Bo Soo Kim, Steven Schulman, Frederick K Korley

Abstract readObservational Study
In one paragraph

Observational study in Journal of critical care, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Right ventricular-protective ventilation in acute respiratory distress syndrome: phenotypes, monitoring and ventilatory management.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  2. Observational
  3. [Risk factors for acute respiratory distress syndrome in patients with traumatic hemorrhagic shock].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2024
    Article
  4. Article
  5. COVID and Cardiovascular Disease: What We Know in 2021.Current atherosclerosis reports · 2021
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Thomas S MetkusDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, United States. Electronic address: tmetkus1@jhmi.edu.
Eliseo GuallarDepartments of Epidemiology and Medicine and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, United States.
Lori SokollDepartment of Pathology, Johns Hopkins University School of Medicine, United States.
David A MorrowCardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, United States.
Gordon TomaselliDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, United States.
Roy BrowerDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, United States.
Bo Soo KimDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, United States.
Steven SchulmanDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, United States.
Frederick K KorleyDepartment of Emergency Medicine, University of Michigan Medical School, United States.
Johns Hopkins University · USBrigham and Women's Hospital · USUniversity of Michigan · US

Funding

PATHOPHYSIOLOGY OF MYOCARDIAL DISEASEST32HL007227 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Chulan Kwon, WENDY S POST · 1985 to 2026
$21.2M
NHLBI NIH HHS T32 HL007227
6 · The paper itself

Abstract

purposeMyocardial injury connotes worse prognosis in the Acute Respiratory Distress Syndrome (ARDS), however the prognostic connotation of changes in cardiac troponin (cTn) levels in ARDS patients is not known.

methodsWe performed a study of 908 ARDS patients enrolled in two previously completed ARDS Network trials. We obtained plasma samples via the NIH BIOLINCC repository and measured cTn using the ARCHITECT STAT high sensitivity troponin-I assay (Abbott Laboratories) at trial day 0 and 3. We constructed Cox proportional hazard models to determine the association between 60-day mortality and quintiles of percentage change in high-sensitivity troponin (ΔhsTnI).

resultsThe median percent change in hsTnI (%ΔhsTnI) from day 0 to day 3 was -58.2% (IQR -79.0 to 0%). After multivariable adjustment, participants with a 32.1% or greater increase in hsTnI between day 0 and day 3 (highest quintile) had a 2.27 fold increased risk for mortality (95% CI 1.29 - 3.99, p = 0.002) as well as fewer ventilator-free and ICU-free days compared to the lowest quintile.

conclusionProgressive myocardial injury in ARDS patients is associated with worse outcome, independent of severity of critical illness. Investigation of the mechanisms underlying this relationship is warranted to guide possible strategies to mitigate myocardial injury in ARDS.

Indexed as

BiomarkersCritical IllnessFemaleHeart InjuriesHumansMaleMiddle AgedOrgan Dysfunction ScoresPrognosisRespiratory Distress SyndromeTroponin IBiomarkersTroponin IARDSCardiacHypoxiaMyocardial injuryTroponin

Identifiers

PMID30138905
PMCPMC6226321
OpenAlexW2887664762

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.